Innoviva (INVA) Return on Sales [ROS] (2011 - 2026)
Innoviva's Return on Sales [ROS] came in at 42.52% for Q2 2026, down 6.09 percentage points from 48.61% a year earlier but up 3.59 percentage points from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Innoviva reported Return on Sales [ROS] of 36.95%, down 10.74 percentage points year-over-year; for FY2025, it was 39.81%, down 6.71 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of -55.54 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was 46.52% in FY2024 (+9.84 pp), 36.68% in FY2023 (+15.04 pp), 21.64% in FY2022 (-74.08 pp) and 95.72% in FY2021 (+0.38 pp).
- The five-year range for quarterly Return on Sales [ROS] is -38.65% (Q2 2023) to 112.65% (Q4 2023).
- Year-over-year, Return on Sales [ROS] has declined for five consecutive quarters, with an average year-over-year change of -5.96 percentage points over the last six quarters.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2023 (a gain of 112.65 percentage points), and the weakest in Q2 2023 (a drop of 114.93 percentage points).
- Business Quant data shows INVA's Return on Sales [ROS] at 38.94% (Q1 2026), 34.02% (Q4 2025) and 32.08% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Innoviva | 1.49 Bn | -801.70 Mn | 90.62 Mn | 42.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.52% |
| Mar 31, 2026 | 38.94% |
| Dec 31, 2025 | 34.02% |
| Sep 30, 2025 | 32.08% |
| Jun 30, 2025 | 48.61% |
| Mar 31, 2025 | 46.74% |
| Dec 31, 2024 | 46.99% |
| Sep 30, 2024 | 48.31% |
| Jun 30, 2024 | 54.74% |
| Mar 31, 2024 | 33.30% |
| Sep 30, 2023 | 112.65% |
| Jun 30, 2023 | -11.89% |
| Mar 31, 2023 | -14.86% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | 76.28% |
| Mar 31, 2022 | 86.31% |
| Dec 31, 2021 | 97.07% |
| Sep 30, 2021 | 96.62% |
| Jun 30, 2021 | 95.77% |
| Mar 31, 2021 | 92.94% |
API Access
Innoviva Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();